Clinical Trial Update: Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS) [Phase 4]

View source ↗

Summary

A Phase 4 trial named AEGIS evaluating alpha-ketoglutarate for geroprotection during coronary artery bypass graft surgery is currently recruiting at National Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Alpha-ketoglutarate (alpha-ketoglutarate)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: CABG | Phase 4 | Status: RECRUITING